MENU
GNLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Genelux (GNLX) Earnings Date & Reports
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer... Show more
A.I. Advisor
published Earnings
GNLX is expected to report earnings to rise 19.05% to -25 cents per share on November 18
Q3'26
Est.
$-0.25
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.01
The last earnings report on August 13 showed earnings per share of -20 cents, beating the estimate of -25 cents. With 192.24K shares outstanding, the current market capitalization sits at 111.76M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
26
Web
https://www.genelux.com